News

​​

April 23, 2019: PrimeStore® MTM opens Sputum-free Molecular Screening for M. tuberculosis Infection

September 24, 2018: Game Changing Tuberculosis Assay Validated for Illumina's MiSeq® Platform

​

March 22, 2018: World TB Day 2018: US Food and Drug Administration Clears PrimeStore® MTM, an Important New Device

​

March 21, 2018: Longhorn Vaccines and Diagnostics LLC receives de novo clearance by the U.S. Food and Drug Administration for PrimeStore® Molecular Transport Medium establishing a new class of microbial nucleic acid stabilization devices for molecular testing

July 20, 2016: Tuberculosis Detection With Cepheid MTB Test Improved By Longhorn's Sample Transport Medium

​

May 22, 2017: PrimeStore® Molecular Transport Medium Aiding Laboratories Tracking H7N9 Avian Influenza

Nov. 2, 2015: Longhorn Vaccines and Diagnostics LLC's PrimeSuite TB™ products included in the 2015 UNITAID Tuberculosis Diagnostics Technology and Market Landscape

Feb. 24, 2010: Longhorn Vaccines and Diagnostics LLC Receives FDA Emergency Use Authorization (EUA) for the First 2009 H1N1 Influenza Assay to Include a Molecular Transport Medium (MTM)

​

​

​